Does Anthem Cover Vyvanse?
The verdict
Covered on most plans
Anthem (Elevance Health) covers Vyvanse through CarelonRx — generic lisdexamfetamine is now the preferred option across commercial, ACA, Medicare Advantage, and Medicaid lines, while brand Vyvanse is non-preferred as generic supply improves. During 2024, Anthem temporarily added brand Vyvanse back to formularies during the shortage — those add-backs are being reversed. A Schedule II 70 mg/day quantity limit and ADHD diagnosis requirement apply; some Anthem regional plans require a prior generic-stimulant trial.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Anthem using your member ID.
Key facts
Anthem (Elevance Health) uses CarelonRx as its PBM — distinct from OptumRx (UHC), CVS Caremark (Aetna), Express Scripts (Cigna) — across commercial, Medicare, ACA, and Medicaid lines.
Anthem / CarelonRx plan documentation
The DEA set the 2026 lisdexamfetamine APQ at 51,290,743 grams (January 5, 2026), up from 39.9 million grams in 2025.
DEA Final Order, effective January 5, 2026
Generic lisdexamfetamine costs ~$200–$360/month cash (or ~$60–$70 with coupon) versus brand Vyvanse at ~$400–$558/month.
GoodRx cash price data
Medicare vs. commercial coverage
Whether Anthem covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Under Anthem Medicare Advantage/Part D plans, generic lisdexamfetamine is covered and preferred via CarelonRx; brand Vyvanse may require prior authorization. A Schedule II 70 mg/day quantity limit applies. Medicare beneficiaries cannot use manufacturer savings cards — the generic is the financially important path. Verify on the Anthem Medicare drug list or CarelonRx formulary for your plan.
Commercial / Employer
Group & marketplace plans
On Anthem Commercial/Employer plans (CarelonRx PBM), generic lisdexamfetamine is preferred at a low tier; brand Vyvanse is non-preferred. On ACA/Individual plans, the same generic-preferred pattern applies with 70 mg/day QL. On Anthem Medicaid managed care plans, generic lisdexamfetamine is covered per state PDL with PA and QL requirements; nominal Medicaid cost-share applies. Some Anthem commercial plans add a prior generic-stimulant step (trial of a preferred generic stimulant before non-preferred agents). Tier varies by Anthem regional plan — verify on the Anthem drug lookup tool or CarelonRx formulary.
The 6 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 6 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Generic lisdexamfetamine: ~$200–$360 per month cash (as low as ~$60–$70 with coupon). Brand Vyvanse: ~$400–$558 per month. Estimates only — varies by pharmacy and dose.
List price with no coverage — before any manufacturer savings card.
With coverage
Generic: preferred-tier copay via CarelonRx (tier varies by Anthem regional plan — verify on the Anthem drug lookup). Brand Vyvanse: higher non-preferred tier copay. Medicaid: nominal ($0–$4 typical). Exact cost-share depends on your specific Anthem plan design.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates and vary by plan tier, Anthem regional plan, pharmacy, and dose. Confirm with the Anthem drug lookup tool or CarelonRx formulary. Medicare members cannot use manufacturer savings cards.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use the Anthem drug lookup tool
Log in to anthem.com or sydney.com (Anthem's member app) and use the drug search to look up 'lisdexamfetamine' or 'Vyvanse.' The tool shows your plan's specific tier, quantity limit, step-therapy requirements, and any PA requirement. Because Anthem tier varies by regional plan, the member-authenticated drug lookup is the most accurate source.
- 2
Call Anthem Member Services
Call the number on the back of your Anthem card to confirm your specific plan's Vyvanse coverage — including whether generic or brand applies, your copay estimate, and whether step therapy or PA is required. Ask about the CarelonRx PA submission process.
- 3
Have your prescriber submit PA through CarelonRx and check pharmacy stock
If prior authorization or step-therapy documentation is required, your prescriber submits clinical documentation through the CarelonRx PA portal including your ADHD or BED diagnosis. Also ask your pharmacy about current generic lisdexamfetamine stock — a shortage-documented PA or pharmacist override allows brand dispensing if the generic is unavailable.
Options if Anthem won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The CarelonRx-preferred option. FDA-approved August 2023; ~$60–$70/month with coupon vs. $400–$558 for brand Vyvanse. Therapeutically equivalent to brand.
Generic amphetamine/dextroamphetamine (Adderall generic)
FDA-approved for ADHD; generally preferred on Anthem/CarelonRx with a ~60 mg/day QL. May be required as the step-therapy agent on plans with a generic-stimulant step before Vyvanse.
Generic methylphenidate (Ritalin)
Non-amphetamine Schedule II ADHD stimulant. Generally preferred low-tier on CarelonRx and may serve as the step-therapy agent on Anthem plans requiring a prior generic-stimulant trial.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Anthem covers both through CarelonRx, but generic lisdexamfetamine is now the formulary-preferred option and brand Vyvanse is non-preferred. In 2024, Anthem temporarily moved brand Vyvanse to preferred status when generic supply was thin during the stimulant shortage — as the DEA's 2026 lisdexamfetamine production quota (51.3 million grams) helps generic supply recover, those temporary add-backs are being reversed. A formulary exception through CarelonRx is typically needed for brand Vyvanse. Verify your current plan status on the Anthem drug lookup.
Anthem applies a Schedule II quantity limit of 70 mg per day for lisdexamfetamine through CarelonRx, consistent with FEP criteria (Policy 5.60.024). Some Anthem regional plans may also apply age-based PA edits for Schedule II stimulants. Prescriptions exceeding 70 mg/day trigger additional clinical review. Tier and QL details vary by Anthem regional plan — verify on the Anthem drug lookup tool or call Anthem member services to confirm your specific plan's exact rules.
Some Anthem commercial and regional plans via CarelonRx require a prior trial and documented failure of a preferred generic stimulant (such as generic amphetamine/dextroamphetamine) before approving Vyvanse as a non-preferred agent. Step therapy requirements are plan-specific and not universal across Anthem's regional plans. Your prescriber can check the step-therapy requirement on the CarelonRx formulary and document the clinical rationale for Vyvanse if a trial of a generic stimulant is not appropriate for you. Verify on the Anthem drug lookup for your plan.
All three reach the same generic-lisdexamfetamine-preferred outcome, but PBMs differ: Anthem uses CarelonRx, UHC uses OptumRx, Cigna uses Express Scripts. CarelonRx's tier varies by Anthem regional plan and is not always published at a single national level (unlike Aetna's CVS Caremark, which has the best-documented FEP numbers). Step-therapy requirements also vary more across Anthem's regional network. For the most accurate Anthem data, use the member-authenticated Anthem drug lookup — do not assume a single national CarelonRx tier applies to your plan.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.